Research-Grade Valsartan Overview
Diovan 320 Novartis is a pharmaceutical-grade angiotensin receptor blocker (ARB) preparation manufactured by Novartis, containing 320mg of valsartan per tablet. This research-quality compound enables laboratory investigations into angiotensin II type 1 receptor (AT1R) antagonism and cardiovascular regulatory mechanisms. Available through Stroid UK Shop, this pharmaceutical preparation provides researchers with standardised valsartan formulations for in-vitro studies examining renin-angiotensin-aldosterone system modulation.
Laboratory Applications for Cardiovascular Research
Research scientists examine valsartan’s selective AT1 receptor antagonist properties in cell culture and tissue studies investigating cardiovascular pathways. Laboratory applications include analysing vasoconstriction mechanisms, studying aldosterone secretion pathways, and examining renal blood flow regulation in experimental models. Researchers investigating cardiovascular modulators utilise this compound to evaluate angiotensin II blockade effects on vascular smooth muscle cells and cardiac tissue preparations. The pharmaceutical-grade formulation enables standardised protocols for examining dose-response relationships in receptor binding assays and functional studies of cardiovascular regulatory systems.
Compound Specifications
| Parameter | Value |
|---|---|
| Active Compound | Valsartan |
| Concentration | 320mg per tablet |
| Manufacturer | Novartis |
| CAS Number | 137862-53-4 |
| Molecular Formula | C₂₄H₂₉N₅O₃ |
| Molecular Weight | 435.52 g/mol |
| Storage | Room temperature, dry conditions |
This pharmaceutical preparation offers researchers access to validated valsartan formulations comparable to standards used in published cardiovascular research studies. Laboratory teams studying receptor modulators and bioactive compounds can integrate these tablets into experimental protocols examining AT1 receptor pharmacology and cardiovascular signalling pathways.
Research Compliance Statement
This pharmaceutical product is supplied strictly for in-vitro laboratory research applications only. Diovan 320 Novartis is not intended for human consumption, clinical use, or any therapeutic applications. Researchers must maintain appropriate laboratory protocols and safety measures when handling this compound. All studies should comply with institutional research guidelines and applicable regulations governing cardiovascular research compounds.
